An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF

Clinical Trial Summary

This Expanded Access Program is intended to facilitate the availability of OFEV to patients suffering from non Idiopathic Pulmonary Fibrosis-Interstitial Lung Disease (non IPF-ILD) with a progressive clinical course despite Standard of Care treatment and for whom no satisfactory authorised alternative therapy exists or who cannot enter a clinical trial.

See also
Status	Clinical Trial	Phase
Terminated	`NCT04119115` - Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases
Active, not recruiting	`NCT04559581` - Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
Recruiting	`NCT05151640` - INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
Recruiting	`NCT02543073` - MSC for Treatment of Interstitial Lung Disease After Allo-HSCT	Phase 1/Phase 2
Completed	`NCT02251964` - Rituximab in Interstitial Pneumonitis	Phase 2/Phase 3
Terminated	`NCT01432080` - Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant	Phase 2
Completed	`NCT01442779` - Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis	Phase 2
Recruiting	`NCT05596760` - Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers	N/A
Recruiting	`NCT05866198` - Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation	N/A
Active, not recruiting	`NCT05321082` - A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)	Phase 3
Completed	`NCT04016168` - Idiopathic Pulmonary Fibrosis and Serum Bank
Recruiting	`NCT00258583` - Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Recruiting	`NCT05855109` - Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Completed	`NCT05719233` - Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease
Recruiting	`NCT04159129` - Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients
Completed	`NCT03313180` - A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis	Phase 3
Completed	`NCT05065190` - A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis	Phase 3
Completed	`NCT03136120` - Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease
Recruiting	`NCT04930666` - BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
Recruiting	`NCT05503030` - Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

NCT number	NCT03843892
Study type	Expanded Access
Source	Boehringer Ingelheim
Contact
Status	Approved for marketing
Phase

An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms